Not Yet RecruitingNCT07686731
Suvorexant 3 - PE-PC
Medication studyAges 18–75United StatesPTSD
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 142
- Sponsor
- Northern California Institute of Research and Education
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT07686731
- Official title
Show the full official title
Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northern California Institute of Research and Education, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Suvorexant and Placebo.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
